← Leaderboards
Yufang Shi
American National Red Cross
$7,759,426
Attributed
$10,055,995
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$10,055,995 · 10
By mechanism
R01$8,279,300 · 7
P01$1,776,695 · 3
Top collaborators
- Songtao Shi8 shared
- Anh D Le6 shared
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineApoptosisGene ExpressionProtooncogeneCellsTransfectionIn VivoT-LymphocyteMediatingImmuneLymphocyteIn VitroBone MarrowDisease ModelAnimalsGraft-Vs-Host DiseaseMolecularImmunoregulationInflammatoryNatural ImmunosuppressionMesenchymal Stem CellsImmunosuppressive AgentsPropertyStem Cells
Grant awards (47)
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION$506,657
R01 · FY2013 · DE
Immunosuppression by Adult Stem Cells$287,423
R01 · FY2013 · GM · contact PI
Immunosuppression by Adult Stem Cells$10,933
R01 · FY2013 · GM · contact PI
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION$544,458
R01 · FY2012 · DE
Immunosuppression by Adult Stem Cells$303,558
R01 · FY2012 · GM · contact PI
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION$17,568
R01 · FY2012 · DE
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION$574,256
R01 · FY2011 · DE
Immunosuppression by Adult Stem Cells$303,558
R01 · FY2011 · GM · contact PI
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION$597,450
R01 · FY2010 · DE
INTERPLAYS BETWEEN THE JAW MESENCHYMAL STEM CELLS AND T LYMPHOCYTES$397,500
R01 · FY2010 · DE
Immunosuppression by Adult Stem Cells$306,624
R01 · FY2010 · GM · contact PI
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION$594,677
R01 · FY2009 · DE
INTERPLAYS BETWEEN THE JAW MESENCHYMAL STEM CELLS AND T LYMPHOCYTES$415,550
R01 · FY2009 · DE
Regulation of RANKL Expression in T-Lymphocytes$288,212
P01 · FY2008 · AI · contact PI
Real-Time PCR Facility Core C$46,066
P01 · FY2008 · AI · contact PI
Flow Cytometry Core B$29,402
P01 · FY2008 · AI · contact PI
Regulation of RANKL Expression in T-Lymphocytes$288,666
P01 · FY2007 · AI · contact PI
Real-Time PCR Facility Core C$46,137
P01 · FY2007 · AI · contact PI
Flow Cytometry Core B$29,447
P01 · FY2007 · AI · contact PI
Regulation of RANKL Expression in T-Lymphocytes$282,938
P01 · FY2006 · AI · contact PI
Real-Time PCR Facility Core C$45,219
P01 · FY2006 · AI · contact PI
Flow Cytometry Core B$28,862
P01 · FY2006 · AI · contact PI
Opioid-Mediated Fas Expression in Lymphocyte Apoptosis$349,875
R01 · FY2005 · AI
Regulation of RANKL Expression in T-Lymphocytes$274,933
P01 · FY2005 · AI
Real-Time PCR Facility Core C$43,939
P01 · FY2005 · AI
Flow Cytometry Core B$28,045
P01 · FY2005 · AI
Opioid-Mediated Fas Expression in Lymphocyte Apoptosis$349,875
R01 · FY2004 · AI
Regulation of RANKL Expression in T-Lymphocytes$273,278
P01 · FY2004 · AI
Real-Time PCR Facility Core C$43,675
P01 · FY2004 · AI
Flow Cytometry Core B$27,876
P01 · FY2004 · AI
Opioid-Mediated Fas Expression in Lymphocyte Apoptosis$349,875
R01 · FY2003 · AI
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS$246,441
R01 · FY2003 · AI
Opioid-Mediated Fas Expression in Lymphocyte Apoptosis$332,381
R01 · FY2002 · AI
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS$231,874
R01 · FY2002 · AI
REGULATION OF MITOGENIC CYTOKINE INDUCED APOPTOSIS$208,988
R01 · FY2002 · CA
REGULATION OF MITOGENIC CYTOKINE INDUCED APOPTOSIS$45,168
R01 · FY2002 · CA
Opioid-Mediated Fas Expression in Lymphocyte Apoptosis$346,948
R01 · FY2001 · AI
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS$197,482
R01 · FY2001 · AI
REGULATION OF MITOGENIC CYTOKINE INDUCED APOPTOSIS$157,143
R01 · FY2001 · CA
REGULATION OF MITOGENIC CYTOKINE INDUCED APOPTOSIS$44,807
R01 · FY2001 · CA
REGULATION OF MITOGENIC CYTOKINE INDUCED APOPTOSIS$44,624
R01 · FY2001 · CA
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS$34,063
R01 · FY2001 · AI
HUMAN IL3 ACTIVATION OF PROTEIN KINASE C AND BCL-2 GENE$21,395
R01 · FY2001 · CA
Opioid-Mediated Fas Expression in Lymphocyte Apoptosis$1
R01 · FY2001 · AI
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS$224,803
R01 · FY2000 · AI
REGULATION OF MITOGENIC CYTOKINE INDUCED APOPTOSIS$196,067
R01 · FY2000 · CA
REGULATION OF MITOGENIC CYTOKINE INDUCED APOPTOSIS$37,278
R01 · FY2000 · CA